Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients.

MLA

Torisu-Itakura, Hitoe, et al. “Monocyte-Derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients.” Journal of Immunotherapy (Hagerstown, Md. : 1997), vol. 30, no. 8, Nov. 2007, pp. 831–38. EBSCOhost, https://doi.org/10.1097/CJI.0b013e318158795b.

APA

Torisu-Itakura, H., Lee, J. H., Huynh, Y., Ye, X., Essner, R., & Morton, D. L. (2007). Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients. Journal of Immunotherapy (Hagerstown, Md. : 1997), 30(8), 831–838. https://doi.org/10.1097/CJI.0b013e318158795b

Chicago

Torisu-Itakura, Hitoe, Jonathan H Lee, Young Huynh, Xing Ye, Richard Essner, and Donald L Morton. 2007. “Monocyte-Derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients.” Journal of Immunotherapy (Hagerstown, Md. : 1997) 30 (8): 831–38. doi:10.1097/CJI.0b013e318158795b.